| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 ABR MYCBP2 GIT2 TIAM2 TBC1D16 SLIT2 DENND10 ARHGEF7 RABGAP1L HERC1 DENND5B GIT1 STXBP5 ARFGEF2 ARFGEF1 EIF2B1 ARHGAP45 PLCE1 | 8.54e-06 | 507 | 233 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 ABR MYCBP2 GIT2 TIAM2 TBC1D16 SLIT2 DENND10 ARHGEF7 RABGAP1L HERC1 DENND5B GIT1 STXBP5 ARFGEF2 ARFGEF1 EIF2B1 ARHGAP45 PLCE1 | 8.54e-06 | 507 | 233 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | ABR MYCBP2 TIAM2 DENND10 ARHGEF7 HERC1 DENND5B ARFGEF2 ARFGEF1 EIF2B1 PLCE1 | 8.96e-05 | 231 | 233 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGAP32 ABR MYCBP2 CD109 GIT2 PTEN TIAM2 TBC1D16 SLIT2 KAT2B NOD1 DENND10 ARHGEF7 SPOCK3 RABGAP1L A2ML1 HERC1 DENND5B GIT1 BMP2K STXBP5 ARFGEF2 ARFGEF1 RICTOR BRCC3 AZIN1 EGFR EIF2B1 SPRED1 ARHGAP45 EIF2AK2 PLCE1 SORL1 | 1.13e-04 | 1418 | 233 | 33 | GO:0030234 |
| GeneOntologyMolecularFunction | GTPase binding | MYO1C MYCBP2 GIT2 DENND10 ARHGEF7 RABGAP1L GNB3 GOLGA4 DENND5B GIT1 CSE1L PLCE1 SORL1 | 3.32e-04 | 360 | 233 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 4.04e-04 | 3 | 233 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | small GTPase binding | MYO1C MYCBP2 GIT2 DENND10 ARHGEF7 RABGAP1L GOLGA4 DENND5B GIT1 CSE1L PLCE1 SORL1 | 4.12e-04 | 321 | 233 | 12 | GO:0031267 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ARHGAP32 SCN11A ERBB2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 ARHGEF7 CNTN5 VPS13A KDR KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 SYNE1 LIFR MFSD2A EGFR SS18L1 UNC5C ROBO1 ULK2 NIN | 4.43e-08 | 819 | 231 | 29 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGAP32 SCN11A ERBB2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 ARHGEF7 CNTN5 VPS13A KDR KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 SYNE1 LIFR MFSD2A EGFR SS18L1 UNC5C ROBO1 ULK2 NIN | 5.32e-08 | 826 | 231 | 29 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGAP32 SCN11A ERBB2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 CNTN5 VPS13A KDR KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 SYNE1 LIFR MFSD2A EGFR SS18L1 UNC5C ROBO1 ULK2 NIN | 1.03e-07 | 802 | 231 | 28 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron projection development | ARHGAP32 SCN11A ERBB2 RIPOR2 MYCBP2 EXT1 COL25A1 PTEN CSMD3 TIAM2 SLIT2 KAT2B PRDM8 CNTN5 VPS13A PCDH15 KDR KIF5B KIF5C HERC1 VASP GOLGA4 DSCAM GIT1 STXBP5 SYNE1 ARFGEF1 NR3C1 LIFR MFSD2A EGFR SS18L1 UNC5C ROBO1 IKBKB ULK2 NIN | 1.13e-07 | 1285 | 231 | 37 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ASXL1 ARHGAP32 SCN11A ERBB2 RIPOR2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 F11R ARHGEF7 CNTN5 VPS13A PCDH15 HRH2 KDR KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 SYNE1 ATP10A LIFR MFSD2A EGFR SS18L1 UNC5C ROBO1 ULK2 NIN | 1.71e-07 | 1194 | 231 | 35 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 SCN11A ERBB2 RIPOR2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 CNTN5 PCDH15 KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 SYNE1 MFSD2A SS18L1 UNC5C ROBO1 ULK2 NIN | 3.33e-07 | 748 | 231 | 26 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron development | ARHGAP32 SCN11A ERBB2 RIPOR2 MYCBP2 EXT1 COL25A1 PTEN CSMD3 TIAM2 SLIT2 KAT2B PRDM8 CNTN5 VPS13A PCDH15 KDR KIF5B KIF5C HERC1 VASP GOLGA4 DSCAM GIT1 STXBP5 SYNE1 ARFGEF1 NR3C1 LIFR MFSD2A EGFR SS18L1 UNC5C ROBO1 IKBKB ULK2 HTT NIN | 9.80e-07 | 1463 | 231 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGAP32 SCN11A ERBB2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 CNTN5 KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 UNC5C ROBO1 ULK2 NIN | 1.74e-06 | 566 | 231 | 21 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | RIPOR2 MYO1C MYCBP2 KAT2A PTEN TBC1D16 SLIT2 KAT2B F11R ARHGEF7 KDR VASP PDCD6IP TAPT1 GIT1 STXBP5 SYNE1 VPS8 CAPZA1 ARFGEF1 RICTOR BRCC3 USP16 ZNF750 ROBO1 ATM IKBKB EIF2AK2 HTT PLCE1 SORL1 | 1.03e-05 | 1189 | 231 | 31 | GO:0044087 |
| GeneOntologyBiologicalProcess | axon development | ARHGAP32 SCN11A ERBB2 MYCBP2 EXT1 COL25A1 PTEN TIAM2 SLIT2 PRDM8 CNTN5 KIF5B KIF5C VASP GOLGA4 DSCAM STXBP5 UNC5C ROBO1 ULK2 NIN | 1.21e-05 | 642 | 231 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | ASXL1 ARHGAP32 MYO1C EXT1 PTEN SLIT2 KAT2B HRH2 KDR GNB3 VASP WNK3 GOLGA4 DSCAM CAPZA1 ARFGEF1 RICTOR SPECC1L EGFR ULK2 | 2.29e-05 | 618 | 231 | 20 | GO:0090066 |
| GeneOntologyBiologicalProcess | axon guidance | ERBB2 MYCBP2 EXT1 SLIT2 CNTN5 KIF5B KIF5C VASP DSCAM UNC5C ROBO1 ULK2 | 9.47e-05 | 285 | 231 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | ERBB2 MYCBP2 EXT1 SLIT2 CNTN5 KIF5B KIF5C VASP DSCAM UNC5C ROBO1 ULK2 | 9.79e-05 | 286 | 231 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP32 ERBB2 RIPOR2 ABR GIT2 TIAM2 SLIT2 F11R GIT1 ARFGEF2 ARFGEF1 ROBO1 ARHGAP45 | 1.04e-04 | 333 | 231 | 13 | GO:0051056 |
| GeneOntologyBiologicalProcess | regulation of ribosome biogenesis | 1.11e-04 | 9 | 231 | 3 | GO:0090069 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ARHGAP32 RIPOR2 MYCBP2 KAT2A PTEN CSMD3 TIAM2 TBC1D16 SLIT2 KAT2B ARHGEF7 GOLGA4 TAPT1 DSCAM SYNE1 MFSD2A SS18L1 ROBO1 IKBKB ULK2 HTT PLCE1 NIN | 1.12e-04 | 863 | 231 | 23 | GO:0031344 |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 1.15e-04 | 43 | 231 | 5 | GO:0021955 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 1.15e-04 | 23 | 231 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | COG6 PGAP1 VPS13A GOLGA4 COPG1 STXBP5 ARFGEF2 COPG2 ARCN1 SEC24C TRAPPC10 HTT SORL1 | 1.24e-04 | 339 | 231 | 13 | GO:0048193 |
| GeneOntologyBiologicalProcess | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 1.25e-04 | 2 | 231 | 2 | GO:0021836 | |
| GeneOntologyBiologicalProcess | organelle localization | KIF18A SCN11A MYO1C KAT2A PTEN ABRAXAS2 KAT2B KIF5B KIF5C PDCD6IP COPG1 LAT2 SYNE1 TSNARE1 COPG2 ARCN1 TRAPPC10 ATM MAD2L1 HTT | 1.35e-04 | 703 | 231 | 20 | GO:0051640 |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 1.37e-04 | 24 | 231 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ARHGAP32 RIPOR2 KAT2A TIAM2 SLIT2 KAT2B ARHGEF7 GOLGA4 TAPT1 DSCAM SS18L1 ROBO1 IKBKB HTT PLCE1 NIN | 1.52e-04 | 494 | 231 | 16 | GO:0031346 |
| GeneOntologyBiologicalProcess | corticospinal tract morphogenesis | 1.57e-04 | 10 | 231 | 3 | GO:0021957 | |
| GeneOntologyBiologicalProcess | regulation of bone development | 2.14e-04 | 11 | 231 | 3 | GO:1903010 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ARHGAP32 RIPOR2 MYCBP2 PTEN CSMD3 TIAM2 TBC1D16 SLIT2 KAT2B ARHGEF7 GOLGA4 TAPT1 DSCAM SYNE1 MFSD2A SS18L1 ROBO1 IKBKB ULK2 HTT PLCE1 NIN | 2.23e-04 | 846 | 231 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | ARHGAP32 PTEN TIAM2 SLIT2 KDR MME GOLGA4 DSCAM IDH2 TERT EGFR SS18L1 ROBO1 ULK2 SORL1 NIN | 2.43e-04 | 515 | 231 | 16 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | KIF18A RIPOR2 MYO1C MYCBP2 KAT2A SLIT2 KAT2B F11R ARHGEF7 CLTC VASP PDCD6IP GIT1 CAPZA1 ARFGEF1 RICTOR SPECC1L | 3.01e-04 | 579 | 231 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 3.01e-04 | 114 | 231 | 7 | GO:0050772 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.26e-04 | 192 | 231 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | ARHGAP32 MYO1C PTEN SLIT2 GNB3 VASP WNK3 GOLGA4 DSCAM CAPZA1 ARFGEF1 RICTOR SPECC1L ULK2 | 3.39e-04 | 426 | 231 | 14 | GO:0032535 |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF18A ERBB2 RIPOR2 CATSPERE SMC1A KAT2A PTEN ABRAXAS2 TBC1D32 KAT2B ARHGEF7 CLTC VPS13A KIF5B KIF5C PDCD6IP GIT1 COPG1 COPG2 SPECC1L AZIN1 TNKS MAD2L1 HTT NIN | 3.57e-04 | 1058 | 231 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | postnatal olfactory bulb interneuron migration | 3.72e-04 | 3 | 231 | 2 | GO:0021827 | |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration using cell-cell interactions | 3.72e-04 | 3 | 231 | 2 | GO:0021823 | |
| GeneOntologyBiologicalProcess | substrate-dependent cerebral cortex tangential migration | 3.72e-04 | 3 | 231 | 2 | GO:0021825 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | PBLD EXT1 ADA F11R PCDH15 AKR1B1 WNK3 EPG5 MFSD2A EGFR RPE65 MUC5AC | 4.08e-04 | 334 | 231 | 12 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | PBLD EXT1 ADA F11R PCDH15 AKR1B1 WNK3 EPG5 MFSD2A EGFR RPE65 MUC5AC | 4.08e-04 | 334 | 231 | 12 | GO:0001894 |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 4.31e-04 | 32 | 231 | 4 | GO:0021952 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 4.36e-04 | 159 | 231 | 8 | GO:0006888 | |
| GeneOntologyBiologicalProcess | behavior | SCN11A EXT1 GIT2 KAT2A PTEN ADA KAT2B VPS13A PCDH15 HRH2 CYP7B1 MME GNB3 BAHCC1 DSCAM GIT1 NR3C1 ARCN1 MFSD2A EGFR UBR3 HTT | 4.54e-04 | 891 | 231 | 22 | GO:0007610 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | KIF18A SCN11A MYO1C ABRAXAS2 KAT2B KIF5B KIF5C PDCD6IP COPG1 LAT2 SYNE1 COPG2 TRAPPC10 ATM MAD2L1 HTT | 4.61e-04 | 546 | 231 | 16 | GO:0051656 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | KIF18A ERBB2 RIPOR2 KAT2A KAT2B ARHGEF7 CLTC PDCD6IP GIT1 SPECC1L AZIN1 | 4.91e-04 | 293 | 231 | 11 | GO:0032886 |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | EXT1 KAT2A KAT2B ST8SIA6 CLTC AKR1B1 SUPT20H NR3C1 GYG1 SLC25A10 | 4.92e-04 | 247 | 231 | 10 | GO:0016051 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | KIF18A RIPOR2 MYO1C MYCBP2 KAT2A TBC1D16 SLIT2 KAT2B F11R ARHGEF7 CLTC KDR PISD KIF5B VASP PDCD6IP TAPT1 GIT1 SYNE1 CAPZA1 ARFGEF1 RICTOR SPECC1L MTBP TNKS ATM CDC6 MAD2L1 HTT | 5.20e-04 | 1342 | 231 | 29 | GO:0033043 |
| GeneOntologyCellularComponent | mitotic spindle | KIF18A SMC1A KAT2A KAT2B ARHGEF7 CLTC GIT1 TNKS CDC6 MAD2L1 NIN | 1.74e-05 | 201 | 234 | 11 | GO:0072686 |
| GeneOntologyCellularComponent | endosome | ARHGAP32 ERBB2 CLTCL1 TBC1D16 DENND10 PIK3C3 RABGAP1L CLTC VPS13A KDR MME RMC1 PLD4 PDCD6IP GIT1 MARCHF8 VPS50 VPS8 ARFGEF2 SLC26A9 GPR107 GPR161 SLC9A3 IGF2R MCTP1 EGFR SNX25 TRAPPC10 HTT SORL1 | 1.89e-05 | 1167 | 234 | 30 | GO:0005768 |
| GeneOntologyCellularComponent | spindle | KIF18A CLTCL1 SMC1A KAT2A ABRAXAS2 KAT2B ARHGEF7 CLTC GIT1 BRCC3 SPECC1L NR3C1 TNKS ATM CDC6 MAD2L1 NIN | 2.47e-05 | 471 | 234 | 17 | GO:0005819 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ARHGAP32 OR7C1 SRP9 EXT1 FADS2B NSDHL PGAP1 UFD1 VPS13A OSBPL8 CYP7B1 KLHL14 OR7A2P PLD4 TAPT1 COPG1 MARCHF8 CYP3A43 SYNE1 ZDHHC14 SLC26A9 ARMC10 COPG2 ATP10A ARCN1 MOSPD1 MFSD2A MCTP1 SEC24C EGFR RPE65 SORL1 | 3.43e-05 | 1327 | 234 | 32 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ARHGAP32 OR7C1 SRP9 EXT1 FADS2B NSDHL PGAP1 UFD1 VPS13A OSBPL8 CYP7B1 KLHL14 OR7A2P PLD4 TAPT1 COPG1 MARCHF8 CYP3A43 ZDHHC14 SLC26A9 ARMC10 COPG2 ATP10A ARCN1 MOSPD1 MFSD2A MCTP1 SEC24C EGFR RPE65 SORL1 | 5.13e-05 | 1293 | 234 | 31 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ARHGAP32 OR7C1 SRP9 EXT1 FADS2B NSDHL PGAP1 UFD1 VPS13A OSBPL8 CYP7B1 KLHL14 OR7A2P PLD4 TAPT1 COPG1 MARCHF8 CYP3A43 ZDHHC14 SLC26A9 ARMC10 COPG2 ATP10A ARCN1 MOSPD1 MFSD2A MCTP1 SEC24C EGFR RPE65 SORL1 | 5.59e-05 | 1299 | 234 | 31 | GO:0098827 |
| GeneOntologyCellularComponent | Golgi membrane | ARHGAP32 EXT1 ST8SIA6 COG6 B3GALT9 GOLGA4 COPG1 MARCHF8 ARFGEF2 ARFGEF1 SLC26A9 COPG2 CHST1 ARCN1 MOSPD1 IGF2R EGFR NIPAL1 TNKS PLCE1 SORL1 | 6.56e-05 | 721 | 234 | 21 | GO:0000139 |
| GeneOntologyCellularComponent | vesicle coat | 1.04e-04 | 67 | 234 | 6 | GO:0030120 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 1.15e-04 | 43 | 234 | 5 | GO:0097431 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ARHGAP32 ERBB2 CLTCL1 MYO1C CD109 PIK3C3 VNN1 CLTC VPS13A CPNE3 TSPAN14 MME RMC1 COPG1 MARCHF8 STXBP5 SLC26A9 COPG2 ARCN1 GPR161 SLC9A3 IGF2R MCTP1 SEC24C EGFR SNX25 ATM ULK2 HTT SORL1 | 1.48e-04 | 1307 | 234 | 30 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ARHGAP32 ERBB2 CLTCL1 MYO1C CD109 PIK3C3 VNN1 CLTC VPS13A CPNE3 TSPAN14 MME RMC1 COPG1 MARCHF8 STXBP5 SLC26A9 COPG2 ARCN1 GPR161 SLC9A3 IGF2R MCTP1 SEC24C EGFR SNX25 ATM ULK2 HTT SORL1 | 1.88e-04 | 1325 | 234 | 30 | GO:0012506 |
| GeneOntologyCellularComponent | coated membrane | 1.92e-04 | 106 | 234 | 7 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 1.92e-04 | 106 | 234 | 7 | GO:0030117 | |
| GeneOntologyCellularComponent | early endosome | ERBB2 CLTCL1 TBC1D16 RABGAP1L KDR MME PLD4 MARCHF8 VPS8 GPR107 SLC9A3 IGF2R EGFR HTT SORL1 | 3.63e-04 | 481 | 234 | 15 | GO:0005769 |
| GeneOntologyCellularComponent | COPI vesicle coat | 3.65e-04 | 13 | 234 | 3 | GO:0030126 | |
| GeneOntologyCellularComponent | RNA-directed RNA polymerase complex | 3.72e-04 | 3 | 234 | 2 | GO:0031379 | |
| GeneOntologyCellularComponent | growth cone | 4.61e-04 | 245 | 234 | 10 | GO:0030426 | |
| GeneOntologyCellularComponent | spindle pole | 5.24e-04 | 205 | 234 | 9 | GO:0000922 | |
| GeneOntologyCellularComponent | site of polarized growth | 5.92e-04 | 253 | 234 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 6.02e-04 | 61 | 234 | 5 | GO:0030660 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ARHGAP32 SCN11A ABR PTEN ADA TIAM2 SLIT2 ARHGEF7 VPS13A HRH2 KDR KIF5B MME KIF5C KLHL14 GNB3 SYNCRIP DSCAM GIT1 SYNE1 ARFGEF2 NR3C1 UNC5C ROBO1 HTT SORL1 NIN | 6.30e-04 | 1228 | 234 | 27 | GO:0036477 |
| GeneOntologyCellularComponent | trans-Golgi network | CLTCL1 COG6 CLTC MME GOLGA4 PLD4 ARFGEF2 ARFGEF1 CHST1 IGF2R SORL1 | 7.02e-04 | 306 | 234 | 11 | GO:0005802 |
| GeneOntologyCellularComponent | coated vesicle | CLTCL1 F8 CLTC VWF COPG1 COPG2 ARCN1 GPR107 IGF2R SEC24C EGFR HTT | 7.88e-04 | 360 | 234 | 12 | GO:0030135 |
| GeneOntologyCellularComponent | kinetochore | 1.02e-03 | 181 | 234 | 8 | GO:0000776 | |
| GeneOntologyCellularComponent | centrosome | KIF18A KAT2A DHX9 ABRAXAS2 KAT2B ARHGEF7 KIF5B PDCD6IP TAPT1 GIT1 PROCR CENPU ARFGEF2 NR3C1 AZIN1 ERCC6L2 TNKS ATM NIN | 1.12e-03 | 770 | 234 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | cytosolic region | 1.13e-03 | 70 | 234 | 5 | GO:0099522 | |
| GeneOntologyCellularComponent | COPI-coated vesicle membrane | 1.18e-03 | 19 | 234 | 3 | GO:0030663 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.53e-03 | 193 | 234 | 8 | GO:0000779 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 1.59e-03 | 45 | 234 | 4 | GO:0099524 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.59e-03 | 45 | 234 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | microtubule organizing center | KIF18A KAT2A DHX9 ABRAXAS2 KAT2B ARHGEF7 KIF5B PDCD6IP TAPT1 GIT1 PROCR CENPU ARFGEF2 SPECC1L NR3C1 AZIN1 ERCC6L2 TNKS ATM HTT NIN | 1.61e-03 | 919 | 234 | 21 | GO:0005815 |
| GeneOntologyCellularComponent | dendrite | ARHGAP32 ABR PTEN ADA SLIT2 HRH2 KIF5B MME KIF5C GNB3 SYNCRIP DSCAM GIT1 SYNE1 ARFGEF2 NR3C1 UNC5C ROBO1 HTT NIN | 1.64e-03 | 858 | 234 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ARHGAP32 ABR PTEN ADA SLIT2 HRH2 KIF5B MME KIF5C GNB3 SYNCRIP DSCAM GIT1 SYNE1 ARFGEF2 NR3C1 UNC5C ROBO1 HTT NIN | 1.69e-03 | 860 | 234 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.80e-03 | 114 | 234 | 6 | GO:0005798 | |
| GeneOntologyCellularComponent | sorting endosome | 1.82e-03 | 6 | 234 | 2 | GO:0097443 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.82e-03 | 6 | 234 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 1.82e-03 | 6 | 234 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | BRISC complex | 1.82e-03 | 6 | 234 | 2 | GO:0070552 | |
| GeneOntologyCellularComponent | SAGA complex | 2.66e-03 | 25 | 234 | 3 | GO:0000124 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 3.00e-03 | 215 | 234 | 8 | GO:0030662 | |
| GeneOntologyCellularComponent | anchoring junction | GIT2 ADA F11R ARHGEF7 CLTC CPNE3 KDR MME AKR1B1 VASP WNK3 PDCD6IP GIT1 PROCR CAPZA1 SPECC1L TSPAN33 IGF2R HMCN1 EGFR EPCAM | 3.28e-03 | 976 | 234 | 21 | GO:0070161 |
| Domain | ARM-type_fold | RIPOR2 CLTCL1 PIK3C3 ANKAR CLTC EIF3M COPG1 ARFGEF2 ARFGEF1 ARMC10 COPG2 RICTOR ZNFX1 HEATR1 CSE1L ATM HTT | 9.79e-07 | 339 | 228 | 17 | IPR016024 |
| Domain | - | RIPOR2 ANKAR COPG1 ARFGEF2 ARFGEF1 ARMC10 COPG2 RICTOR HEATR1 CSE1L HTT | 9.31e-05 | 222 | 228 | 11 | 1.25.10.10 |
| Domain | Clathrin_H-chain_propeller_rpt | 1.48e-04 | 2 | 228 | 2 | IPR022365 | |
| Domain | Coatomer_g_Cpla | 1.48e-04 | 2 | 228 | 2 | IPR032154 | |
| Domain | GIT | 1.48e-04 | 2 | 228 | 2 | SM00555 | |
| Domain | GIT1_C | 1.48e-04 | 2 | 228 | 2 | PF12205 | |
| Domain | GIT1/2_CC | 1.48e-04 | 2 | 228 | 2 | IPR032352 | |
| Domain | Clathrin-link | 1.48e-04 | 2 | 228 | 2 | PF09268 | |
| Domain | - | 1.48e-04 | 2 | 228 | 2 | 2.130.10.110 | |
| Domain | - | 1.48e-04 | 2 | 228 | 2 | 2.60.40.1480 | |
| Domain | Hist_acetylase_PCAF | 1.48e-04 | 2 | 228 | 2 | IPR016376 | |
| Domain | Clathrin_heavy_chain | 1.48e-04 | 2 | 228 | 2 | IPR016341 | |
| Domain | COP-gamma_platf | 1.48e-04 | 2 | 228 | 2 | PF08752 | |
| Domain | GIT_SHD | 1.48e-04 | 2 | 228 | 2 | PF08518 | |
| Domain | Coatomer_g_Cpla | 1.48e-04 | 2 | 228 | 2 | PF16381 | |
| Domain | Coatomer_gsu_app_Ig-like-sub | 1.48e-04 | 2 | 228 | 2 | IPR013040 | |
| Domain | Clathrin_H-chain_propeller_N | 1.48e-04 | 2 | 228 | 2 | IPR001473 | |
| Domain | GIT_CC | 1.48e-04 | 2 | 228 | 2 | PF16559 | |
| Domain | GIT1_C | 1.48e-04 | 2 | 228 | 2 | IPR022018 | |
| Domain | PCAF_N | 1.48e-04 | 2 | 228 | 2 | IPR009464 | |
| Domain | GIT_SHD | 1.48e-04 | 2 | 228 | 2 | IPR013724 | |
| Domain | Clathrin_H-chain_link/propller | 1.48e-04 | 2 | 228 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 1.48e-04 | 2 | 228 | 2 | PF01394 | |
| Domain | Coatomer_gsu | 1.48e-04 | 2 | 228 | 2 | IPR017106 | |
| Domain | Clathrin_H-chain_linker_core | 1.48e-04 | 2 | 228 | 2 | IPR015348 | |
| Domain | PCAF_N | 1.48e-04 | 2 | 228 | 2 | PF06466 | |
| Domain | Clathrin_H-chain_linker | 4.42e-04 | 3 | 228 | 2 | IPR012331 | |
| Domain | CLH | 4.42e-04 | 3 | 228 | 2 | SM00299 | |
| Domain | ARM-like | RIPOR2 ANKAR COPG1 ARFGEF2 ARFGEF1 ARMC10 COPG2 RICTOR HEATR1 CSE1L HTT | 5.04e-04 | 270 | 228 | 11 | IPR011989 |
| Domain | Ig_I-set | 5.59e-04 | 190 | 228 | 9 | IPR013098 | |
| Domain | I-set | 5.59e-04 | 190 | 228 | 9 | PF07679 | |
| Domain | DCB_dom | 8.76e-04 | 4 | 228 | 2 | IPR032629 | |
| Domain | IF-2B | 8.76e-04 | 4 | 228 | 2 | PF01008 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 8.76e-04 | 4 | 228 | 2 | IPR015873 | |
| Domain | Sec7_C | 8.76e-04 | 4 | 228 | 2 | IPR015403 | |
| Domain | DUF1981 | 8.76e-04 | 4 | 228 | 2 | PF09324 | |
| Domain | IF-2B-related | 8.76e-04 | 4 | 228 | 2 | IPR000649 | |
| Domain | Sec7_N | 8.76e-04 | 4 | 228 | 2 | IPR032691 | |
| Domain | Sec7_N | 8.76e-04 | 4 | 228 | 2 | PF12783 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 8.76e-04 | 4 | 228 | 2 | IPR016245 | |
| Domain | DCB | 8.76e-04 | 4 | 228 | 2 | PF16213 | |
| Domain | - | 8.76e-04 | 4 | 228 | 2 | 3.30.310.30 | |
| Domain | CTCK_1 | 1.28e-03 | 18 | 228 | 3 | PS01185 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX47 ASXL1 HIVEP1 MYO1C MYCBP2 SMC1A PSMA4 KDM3B KAT2A ABRAXAS2 UFD1 CPNE3 KIF5B EIF3M SUPT20H COPG1 CAPZA1 CENPU BRCC3 ATE1 USP16 ARCN1 USP26 IGF2R CSE1L SS18L1 TNKS MAD2L1 NIN | 7.91e-11 | 1005 | 238 | 29 | 19615732 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 DDX47 HIVEP1 MYO1C TRIM4 SMC1A PSMA4 DHX9 NSDHL CLTC KIF5B AKR1B1 EIF3M GOLGA4 ADGRA3 SYNCRIP PDCD6IP NUP107 COPG1 SYNE1 CAPZA1 HEATR1 IDH2 ARCN1 PWP1 IGF2R CSE1L GTF3C2 EIF2B1 PDCD11 ATM EIF2AK2 | 3.94e-09 | 1425 | 238 | 32 | 30948266 |
| Pubmed | ARHGAP32 ERBB2 ABR SMC1A PSMA4 DHX9 OSBPL8 KIF5B MED17 GOLGA4 SYNCRIP PDCD6IP CAPZA1 COPG2 RICTOR ATE1 ARCN1 IGF2R CSE1L SEC24C EGFR ROBO1 | 4.63e-09 | 708 | 238 | 22 | 39231216 | |
| Pubmed | DDX47 CLTCL1 DCAF8 MYO1C PSMA4 ECD CD109 SRP9 COG6 UFD1 CLTC OSBPL8 EIF3M SYNCRIP PDCD6IP COPG1 BMP2K VPS8 CAPZA1 COPG2 HEATR1 SPECC1L IDH2 FHIP2A ARCN1 LIFR CSE1L EIF2B1 TRAPPC10 PDCD11 ATM IKBKB | 5.05e-09 | 1440 | 238 | 32 | 30833792 | |
| Pubmed | DDX47 MYO1C SMC1A PSMA4 SRP9 DHX9 UFD1 CLTC TSPAN14 KIF5B KIF5C GNB3 GOLGA4 SYNCRIP PDCD6IP SYNE1 CAPZA1 COPG2 IDH2 ARCN1 CSE1L EIF2B1 EIF2AK2 | 9.30e-09 | 803 | 238 | 23 | 36517590 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYO1C MYCBP2 SMC1A EXT1 GIT2 DHX9 ABRAXAS2 NUAK1 PIK3C3 ARHGEF7 CLTC KIF5B KIF5C HERC1 AKR1B1 EIF3M SYNCRIP PDCD6IP GIT1 COPG1 CAPZA1 COPG2 BRCC3 HEATR1 AZIN1 EIF2B1 TSPAN7 EIF2AK2 MAD2L1 | 2.00e-08 | 1284 | 238 | 29 | 17353931 |
| Pubmed | MYO1C KDM3B DHX9 CLTC VPS13A GOLGA4 PDCD6IP DSCAM NUP107 COPG1 BMP2K ARFGEF2 ARFGEF1 COPG2 RICTOR SPECC1L ARCN1 IGF2R SEC24C EGFR UNC5C ROBO1 | 2.43e-08 | 777 | 238 | 22 | 35844135 | |
| Pubmed | 3.17e-08 | 6 | 238 | 4 | 20231535 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX47 SMC1A PSMA4 KDM3B SRP9 DHX9 NSDHL HPF1 CLTC CPNE3 OSBPL8 EIF3M SYNCRIP PDCD6IP COPG1 BMP2K COPG2 HEATR1 IDH2 TERT USP16 ARCN1 ZNF546 PWP1 SEC24C SLC25A10 PDCD11 EIF2AK2 MAD2L1 | 3.51e-08 | 1318 | 238 | 29 | 30463901 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX47 SMC1A DHX9 CPNE3 MED12L GNB3 VASP SYNCRIP PDCD6IP NUP107 COPG1 CAPZA1 ARFGEF2 COPG2 ARCN1 CSE1L SEC24C ATM | 1.32e-07 | 582 | 238 | 18 | 20467437 |
| Pubmed | 2.03e-07 | 124 | 238 | 9 | 35516420 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 MYO1C TRIM4 MYCBP2 PSMA4 DHX9 NSDHL UFD1 CLTC CPNE3 SYNCRIP PDCD6IP COPG1 SYNE1 COPG2 RICTOR IDH2 ARCN1 EPG5 CSE1L SLC25A10 | 2.09e-07 | 807 | 238 | 21 | 30575818 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ZNF346 GIT2 UFD1 TAF1 PDCD6IP COPG2 HEATR1 NR3C1 ARCN1 CSE1L SEC24C GTF3C2 ATM MAD2L1 | 3.16e-07 | 370 | 238 | 14 | 22922362 |
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 25293577 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 20135347 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX47 KIF18A ZNF346 MYCBP2 SMC1A TRAIP DHX9 PIK3C3 MED17 SYNCRIP CENPU HEATR1 ARCN1 PWP1 CSE1L GTF3C2 EIF2B1 PDCD11 CDC6 EIF2AK2 | 3.38e-07 | 759 | 238 | 20 | 35915203 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ERBB2 PSMA4 EXT1 PLIN2 ODR4 RABGAP1L UFD1 VPS13A PISD TSPAN14 KIF5C HERC1 AKR1B1 VASP ADGRA3 TAPT1 PROCR ARFGEF2 ARFGEF1 COPG2 ATE1 IGF2R ATM EPCAM | 3.52e-07 | 1061 | 238 | 24 | 33845483 |
| Pubmed | SMC1A DHX9 CLTC KIF5B EIF3M SYNCRIP UBR2 PDCD6IP NUP107 COPG1 CAPZA1 ARFGEF2 ARFGEF1 GPR161 CSE1L SEC24C | 3.64e-07 | 494 | 238 | 16 | 26831064 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF18A MYCBP2 SMC1A GIT2 DHX9 NSDHL TBC1D32 SLIT2 RABGAP1L CPNE3 PISD KIF5C EIF3M VASP SYNCRIP NUP107 GIT1 VPS50 CAPZA1 HEATR1 IDH2 CSE1L GTF3C2 EIF2B1 TRAPPC10 MUC5AC SORL1 | 4.59e-07 | 1321 | 238 | 27 | 27173435 |
| Pubmed | DDX47 ERBB2 MYO1C PLIN2 ODR4 CLTC MED17 AKR1B1 VASP SYNCRIP SPECC1L ATE1 IGF2R CSE1L EIF2B1 EPCAM | 4.63e-07 | 503 | 238 | 16 | 36217030 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 5.36e-07 | 139 | 238 | 9 | 25476789 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CLTCL1 MYO1C PSMA4 COG6 CLTC EIF3M MRI1 COPG1 CAPZA1 COPG2 SPECC1L IDH2 ARCN1 SEC24C EGFR SLC25A10 UBR3 EPCAM | 6.16e-07 | 647 | 238 | 18 | 26618866 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 6.26e-07 | 104 | 238 | 8 | 31240132 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 MYO1C MYCBP2 SMC1A PSMA4 DHX9 UFD1 A2ML1 CLTC CPNE3 KIF5B EIF3M GOLGA4 SYNCRIP PDCD6IP NUP107 COPG1 CAPZA1 RICTOR HEATR1 USP16 ARCN1 CSE1L SEC24C GTF3C2 PDCD11 EIF2AK2 | 7.28e-07 | 1353 | 238 | 27 | 29467282 |
| Pubmed | DCAF8 PSMA4 DHX9 UFD1 CLTC VPS13A OSBPL8 EIF3M NUP107 COPG1 CAPZA1 ARFGEF1 COPG2 HEATR1 ARCN1 IGF2R CSE1L EIF2AK2 | 7.67e-07 | 657 | 238 | 18 | 36180527 | |
| Pubmed | ASXL1 RIPOR2 CSMD3 RABGAP1L CLTC UBR2 STXBP5 SYNE1 VPS8 FHIP2A EPG5 SEC24C ULK2 PLCE1 | 9.82e-07 | 407 | 238 | 14 | 12693553 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 26193216 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 27993934 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 31318186 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 27182061 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 11013081 | ||
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 10428811 | ||
| Pubmed | DCAF8 MYCBP2 ECD ADA DHX9 NSDHL ABRAXAS2 CLTC VPS13A OSBPL8 GOLGA4 SYNCRIP TAPT1 NUP107 SYNE1 RICTOR HEATR1 NR3C1 USP16 LIFR IGF2R SEC24C GTF3C2 EGFR PDCD11 ROBO1 ATM NIN | 1.39e-06 | 1487 | 238 | 28 | 33957083 | |
| Pubmed | ARHGAP32 RIPOR2 HIVEP1 ARHGEF7 CLTC KIF5B TAF1 GAREM1 VWF SUPT20H PDCD6IP SYNE1 SPECC1L CSE1L ROBO1 | 1.54e-06 | 486 | 238 | 15 | 20936779 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX47 MYCBP2 SMC1A SRP9 DHX9 NSDHL ARHGEF7 CLTC CPNE3 PCDH15 MED17 SYNCRIP SUPT20H PDCD6IP SYNE1 DPYSL4 IDH2 PWP1 CSE1L SEC24C SS18L1 SLC25A10 ATM | 1.79e-06 | 1082 | 238 | 23 | 38697112 |
| Pubmed | DDX47 CLTCL1 ABR MYO1C MYCBP2 DHX9 PIK3C3 CLTC OSBPL8 KIF5B MED17 SYNCRIP PDCD6IP NUP107 GIT1 VPS50 ARFGEF2 HEATR1 ARCN1 IGF2R CSE1L GYG1 ARHGAP45 EIF2AK2 | 1.90e-06 | 1168 | 238 | 24 | 19946888 | |
| Pubmed | MYBPH HIVEP1 MYCBP2 SMC1A GIT2 CLTC MED12L TAF1 VWF GIT1 SYNE1 GYG1 SPRED1 TNKS PLCE1 | 2.03e-06 | 497 | 238 | 15 | 23414517 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX47 MYO1C MYCBP2 SMC1A PSMA4 SRP9 DHX9 ABRAXAS2 UFD1 CLTC PISD KIF5B MED17 SYNCRIP MRI1 NUP107 COPG1 CAPZA1 BRCC3 ARCN1 CSE1L GTF3C2 SLC25A10 CDC6 MAD2L1 | 2.05e-06 | 1257 | 238 | 25 | 37317656 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | DCAF8 SMC1A ECD SRP9 SLIT2 ODR4 A2ML1 CPNE3 KIF5B NUP107 COPG1 HEATR1 ARCN1 PWP1 IGF2R CSE1L | 2.40e-06 | 571 | 238 | 16 | 37167062 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DDX47 MYO1C PSMA4 KDM3B NSDHL ABRAXAS2 A2ML1 CLTC KIF5B EIF3M VASP PDCD6IP COPG1 PROCR CAPZA1 ARFGEF1 DPYSL4 BRCC3 NR3C1 ARCN1 IGF2R GYG1 SLC25A10 PDCD11 CDA MAD2L1 | 2.84e-06 | 1367 | 238 | 26 | 32687490 |
| Pubmed | MYO1C MYCBP2 CLTC OSBPL8 KIF5B SYNCRIP PDCD6IP NUP107 COPG1 COPG2 HEATR1 PWP1 IGF2R CSE1L SEC24C PDCD11 ATM | 3.10e-06 | 653 | 238 | 17 | 22586326 | |
| Pubmed | 3.13e-06 | 5 | 238 | 3 | 12473661 | ||
| Pubmed | 3.13e-06 | 5 | 238 | 3 | 18834332 | ||
| Pubmed | KIF18A ARHGAP32 MYO1C MYCBP2 PTEN ABRAXAS2 CLTC VPS13A HERC1 GOLGA4 UBR2 NUP107 COPG2 RICTOR BRCC3 IGF2R CSE1L EGFR UBR3 ROBO1 MAD2L1 NIN | 3.76e-06 | 1049 | 238 | 22 | 27880917 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF8 SMC1A PSMA4 ECD CD109 PTEN ABRAXAS2 UFD1 CPNE3 OSBPL8 PRMT9 SYNCRIP PDCD6IP COPG1 BRCC3 HEATR1 ATE1 PWP1 CSE1L TNKS SORL1 | 4.14e-06 | 974 | 238 | 21 | 28675297 |
| Pubmed | RABGAP1L CPNE3 KIF5B MME GOLGA4 SYNE1 VPS8 ARFGEF2 ARFGEF1 IGF2R EGFR SPRED1 | 4.42e-06 | 339 | 238 | 12 | 37232246 | |
| Pubmed | ZNF346 ERBB2 SMC1A GIT2 DHX9 ARHGEF7 CLTC SYNCRIP NUP107 GIT1 COPG1 RICTOR SPECC1L ARCN1 GTF3C2 EIF2AK2 | 4.60e-06 | 601 | 238 | 16 | 33658012 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 5.01e-06 | 182 | 238 | 9 | 30711629 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX47 SMC1A PSMA4 ECD SRP9 DHX9 ARHGEF7 UFD1 CLTC OSBPL8 KIF5B EIF3M GOLGA4 SYNCRIP PDCD6IP GIT1 COPG1 CAPZA1 ARCN1 PWP1 CSE1L SEC24C EGFR SLC25A10 CDA EIF2AK2 | 5.26e-06 | 1415 | 238 | 26 | 28515276 |
| Pubmed | PSMA4 DHX9 UFD1 CLTC VPS13A OSBPL8 EIF3M COPG1 CAPZA1 HEATR1 ARCN1 IGF2R CSE1L | 5.53e-06 | 408 | 238 | 13 | 33766124 | |
| Pubmed | Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. | 6.07e-06 | 18 | 238 | 4 | 21810271 | |
| Pubmed | Ranking novel cancer driving synthetic lethal gene pairs using TCGA data. | 6.23e-06 | 6 | 238 | 3 | 27438146 | |
| Pubmed | 6.23e-06 | 6 | 238 | 3 | 10805755 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | ERBB2 MYCBP2 SMC1A PSMA4 EXT1 SLIT2 TAF1 VASP GIT1 EGFR UNC5C ROBO1 | 7.67e-06 | 358 | 238 | 12 | 32460013 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SCN11A ZNF486 MYO1C PSMA4 PBLD TIAM2 SLIT2 CLTC CPNE3 MME AKR1B1 VASP VWF PDCD6IP VPS50 CAPZA1 SLC9A3 IGF2R CSE1L EPCAM SORL1 | 7.86e-06 | 1016 | 238 | 21 | 19056867 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DCAF8 SMC1A PSMA4 KDM3B SRP9 DHX9 ABRAXAS2 UFD1 KIF5B HERC1 EIF3M VASP SYNCRIP PDCD6IP GIT1 COPG1 CAPZA1 ARFGEF2 BRCC3 NR3C1 ATE1 ARCN1 CSE1L SEC24C IKBKB HTT | 8.59e-06 | 1455 | 238 | 26 | 22863883 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX47 MYCBP2 SMC1A DHX9 SLIT2 F11R CLTC CPNE3 KIF5B SYNCRIP PDCD6IP NUP107 SYNE1 CAPZA1 HEATR1 SPECC1L ARCN1 IGF2R CSE1L SEC24C PDCD11 | 8.85e-06 | 1024 | 238 | 21 | 24711643 |
| Pubmed | DCAF8 MYCBP2 SMC1A HPF1 CLTC OSBPL8 ZNF841 TAF1 KIF5C VWF SUPT20H DSCAM GIT1 SYNE1 ARFGEF2 ZNFX1 BRCC3 USP16 ARCN1 TSPAN7 ROBO1 SPRED1 TNKS ATM | 9.47e-06 | 1285 | 238 | 24 | 35914814 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX47 MYO1C SMC1A CD109 SRP9 DHX9 CLTC KIF5B ADGRA3 SYNCRIP COPG1 BMP2K SYNE1 CAPZA1 HEATR1 SPECC1L CSE1L EIF2B1 PDCD11 EIF2AK2 | 9.85e-06 | 949 | 238 | 20 | 36574265 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | KIF18A ERBB2 MYCBP2 CD109 EXT1 PGAP1 KIF5B ADGRA3 UBR2 PROCR ARFGEF2 ARFGEF1 BRCC3 GPR107 LIFR IGF2R SEC24C EGFR ROBO1 ATM EIF2AK2 HTT SORL1 | 9.86e-06 | 1201 | 238 | 23 | 35696571 |
| Pubmed | 1.07e-05 | 152 | 238 | 8 | 34299191 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 21295525 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 21029358 | ||
| Pubmed | 1.09e-05 | 7 | 238 | 3 | 10896954 | ||
| Pubmed | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. | 1.09e-05 | 7 | 238 | 3 | 20446891 | |
| Pubmed | GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal adhesion turnover. | 1.09e-05 | 7 | 238 | 3 | 16628223 | |
| Pubmed | Kif18a is specifically required for mitotic progression during germ line development. | 1.09e-05 | 7 | 238 | 3 | 25824710 | |
| Pubmed | MYO1C MYCBP2 PSMA4 CD109 KDM3B SRP9 DHX9 NSDHL PIK3C3 CLTC OSBPL8 PISD EIF3M SYNCRIP PDCD6IP COPG1 IGF2R SEC24C EGFR SLC25A10 PDCD11 ROBO1 IKBKB EIF2AK2 | 1.10e-05 | 1297 | 238 | 24 | 33545068 | |
| Pubmed | MYO1C DHX9 NSDHL CLTC KIF5B AKR1B1 VASP COPG1 RICTOR IDH2 IGF2R | 1.15e-05 | 312 | 238 | 11 | 37120454 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.16e-05 | 202 | 238 | 9 | 33005030 | |
| Pubmed | ARHGAP32 ABR MYCBP2 GIT2 ARHGEF7 CLTC KIF5B KIF5C WNK3 GOLGA4 PDCD6IP DSCAM GIT1 SYNE1 DPYSL4 ZNFX1 SPECC1L IGF2R SEC24C TNKS | 1.22e-05 | 963 | 238 | 20 | 28671696 | |
| Pubmed | 1.30e-05 | 156 | 238 | 8 | 29961565 | ||
| Pubmed | PSMA4 SRP9 GIT2 ABRAXAS2 ODR4 ARHGEF7 EIF3M GIT1 CAPZA1 CENPU RICTOR BRCC3 | 1.32e-05 | 378 | 238 | 12 | 34315543 | |
| Pubmed | ZNF486 EXT1 KAT2A NSDHL NOD1 NUAK1 ODR4 ARHGEF7 CLTC EIF3M DENND5B SUPT20H PDCD6IP PROCR RICTOR HEATR1 USP16 GPR107 AZIN1 MFSD2A SLC25A10 MTBP ULK2 HTT | 1.60e-05 | 1327 | 238 | 24 | 32694731 | |
| Pubmed | ZNF346 CLTCL1 SMC1A PSMA4 SRP9 DHX9 RABGAP1L CLTC KIF5B KIF5C EIF3M SYNCRIP CAPZA1 COPG2 ARCN1 PWP1 IGF2R CSE1L EIF2B1 PDCD11 EIF2AK2 MAD2L1 | 1.64e-05 | 1153 | 238 | 22 | 29845934 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ASXL1 CATSPERE GIT2 PTH2R PLIN2 ABRAXAS2 KAT2B COG6 ARHGEF7 HPF1 VPS13A EIF4E3 HERC1 GNB3 COPG1 CYP3A43 MOSPD1 GPR107 PWP1 EGFR TRAPPC10 CDC6 IKBKB | 1.68e-05 | 1242 | 238 | 23 | 30973865 |
| Pubmed | 1.73e-05 | 8 | 238 | 3 | 17310244 | ||
| Pubmed | 1.73e-05 | 8 | 238 | 3 | 8940050 | ||
| Pubmed | Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization. | 1.73e-05 | 8 | 238 | 3 | 26659946 | |
| Pubmed | Novel isotypic gamma/zeta subunits reveal three coatomer complexes in mammals. | 1.73e-05 | 8 | 238 | 3 | 14729954 | |
| Pubmed | Robo4 is a vascular-specific receptor that inhibits endothelial migration. | 1.73e-05 | 8 | 238 | 3 | 12941633 | |
| Pubmed | 1.73e-05 | 8 | 238 | 3 | 10892742 | ||
| Pubmed | ARHGAP32 MYO1C DHX9 CLTC OSBPL8 KIF5B KIF5C GNB3 AKR1B1 SYNCRIP VWF PDCD6IP GIT1 SYNE1 CAPZA1 ARFGEF2 DPYSL4 ZNFX1 SPECC1L IDH2 ARCN1 CSE1L SEC24C TRAPPC10 CPNE4 | 1.89e-05 | 1431 | 238 | 25 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX47 MYO1C SMC1A ECD CD109 DHX9 CLTC CPNE3 PISD KIF5B EIF3M SYNCRIP PDCD6IP CAPZA1 HEATR1 SPECC1L USP16 ARCN1 PWP1 CSE1L EGFR PDCD11 EIF2AK2 | 2.02e-05 | 1257 | 238 | 23 | 36526897 |
| Pubmed | Large-scale phage-based screening reveals extensive pan-viral mimicry of host short linear motifs. | 2.04e-05 | 24 | 238 | 4 | 37100772 | |
| Pubmed | MYO1C ADA DHX9 PRDM8 CLTC CPNE3 SYNCRIP COPG1 SYNE1 CAPZA1 COPG2 HEATR1 ARCN1 CSE1L HMCN1 CDA CPNE4 EIF2AK2 | 2.37e-05 | 844 | 238 | 18 | 25963833 | |
| Pubmed | DDX47 SMC1A PSMA4 KDM3B KAT2A DHX9 UFD1 CPNE3 TAF1 MED17 AKR1B1 EIF3M SUPT20H PDCD6IP CSE1L GTF3C2 EIF2B1 ATM EIF2AK2 MAD2L1 | 2.53e-05 | 1014 | 238 | 20 | 32416067 | |
| Pubmed | 2.58e-05 | 9 | 238 | 3 | 10330411 | ||
| Pubmed | 2.58e-05 | 9 | 238 | 3 | 20838624 | ||
| Pubmed | A single binding site for dilysine retrieval motifs and p23 within the gamma subunit of coatomer. | 2.58e-05 | 9 | 238 | 3 | 9751720 | |
| Pubmed | COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP. | 2.58e-05 | 9 | 238 | 3 | 10921873 | |
| Pubmed | 2.58e-05 | 9 | 238 | 3 | 27340174 | ||
| Pubmed | 2.58e-05 | 9 | 238 | 3 | 32601248 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 CLTCL1 ABR MYCBP2 PER1 KDM3B KAT2A TIAM2 TBC1D16 NUAK1 HERC1 GAREM1 BAHCC1 LAT2 TSNARE1 ARFGEF2 IGF2R TXNRD3 PDCD11 ULK2 HTT | 2.72e-05 | 1105 | 238 | 21 | 35748872 |
| Pubmed | 2.73e-05 | 225 | 238 | 9 | 31478661 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 MYO1C MYCBP2 SMC1A KDM3B DHX9 CLTC GOLGA4 GIT1 ARFGEF2 RICTOR USP16 PWP1 SEC24C EGFR TRAPPC10 ATM | 2.78e-05 | 774 | 238 | 17 | 15302935 |
| Pubmed | 2.84e-05 | 26 | 238 | 4 | 24067654 | ||
| Pubmed | 2.88e-05 | 52 | 238 | 5 | 20114047 | ||
| Pubmed | TRIM4 MYCBP2 KDM3B CLTC KIF5B TAF1 MED17 CAPZA1 HEATR1 SPECC1L ARCN1 GTF3C2 PDCD11 HTT | 2.93e-05 | 549 | 238 | 14 | 38280479 | |
| Pubmed | 3.01e-05 | 285 | 238 | 10 | 21423176 | ||
| Interaction | VPS33A interactions | ARHGAP32 SMC1A GIT2 PIK3C3 RABGAP1L CLTC NUP107 GIT1 VPS8 BRCC3 NR3C1 SEC24C EGFR TNKS NIN | 2.60e-07 | 253 | 232 | 15 | int:VPS33A |
| Interaction | ATG16L1 interactions | ARHGAP32 ZNF346 MYCBP2 SMC1A PSMA4 ECD SRP9 CCDC168 GIT2 DHX9 NOD1 PIK3C3 CLTC OSBPL8 HERC1 MED17 EIF3M VASP DENND5B NUP107 LAT2 VPS50 CAPZA1 RICTOR SPECC1L NR3C1 FHIP2A PWP1 IGF2R EGFR EIF2B1 ROBO1 ATM ARHGAP45 | 5.04e-07 | 1161 | 232 | 34 | int:ATG16L1 |
| Interaction | HUWE1 interactions | ASXL1 DCAF8 MYCBP2 SMC1A PSMA4 ECD SRP9 ABRAXAS2 SLIT2 ODR4 ARHGEF7 UFD1 A2ML1 CLTC CPNE3 KIF5B KIF5C RMC1 EIF3M NUP107 GIT1 COPG1 CAPZA1 BRCC3 HEATR1 ARCN1 PWP1 IGF2R CSE1L EGFR ATM CDC6 HTT | 5.42e-07 | 1110 | 232 | 33 | int:HUWE1 |
| Interaction | RAB11A interactions | NSDHL KAT2B RABGAP1L CLTC VPS13A CPNE3 OSBPL8 KIF5B MME GOLGA4 DENND5B VPS50 VPS8 ARFGEF2 ARFGEF1 IDH2 NR3C1 GPR161 IGF2R EGFR UNC5C TRAPPC10 PDCD11 ROBO1 SPRED1 HTT | 3.82e-06 | 830 | 232 | 26 | int:RAB11A |
| Interaction | KCNA3 interactions | ARHGAP32 ERBB2 ABR MYO1C SMC1A PSMA4 DHX9 VPS13A OSBPL8 KIF5B MED17 GOLGA4 SYNCRIP PDCD6IP CAPZA1 COPG2 RICTOR SPECC1L ATE1 ARCN1 IGF2R CSE1L SEC24C EGFR ROBO1 SORL1 | 8.99e-06 | 871 | 232 | 26 | int:KCNA3 |
| Interaction | ROBO4 interactions | 1.56e-05 | 14 | 232 | 4 | int:ROBO4 | |
| Interaction | ARF1 interactions | ERBB2 PLIN2 CLTC HERC1 GIT1 COPG1 RICTOR ARCN1 IGF2R SEC24C EGFR EIF2B1 HTT | 2.52e-05 | 282 | 232 | 13 | int:ARF1 |
| Interaction | GPR17 interactions | COG6 PRMT9 VPS50 VPS8 ARFGEF2 ARFGEF1 HEATR1 FHIP2A CSE1L UBR3 ATM CDC6 HTT | 2.61e-05 | 283 | 232 | 13 | int:GPR17 |
| Interaction | FBXW7 interactions | ZNF346 ERBB2 MYO1C MYCBP2 SMC1A PSMA4 EXT1 GIT2 PTEN DHX9 ARHGEF7 UFD1 CLTC EIF4E3 MED17 SYNCRIP NUP107 GIT1 COPG1 RPAIN RICTOR SPECC1L NR3C1 ARCN1 PWP1 CSE1L GTF3C2 EGFR SPRED1 MTBP EIF2AK2 | 2.67e-05 | 1215 | 232 | 31 | int:FBXW7 |
| Interaction | KLHL4 interactions | 3.53e-05 | 33 | 232 | 5 | int:KLHL4 | |
| Interaction | CENPQ interactions | 3.58e-05 | 108 | 232 | 8 | int:CENPQ | |
| Interaction | CHMP4B interactions | DDX47 KIF18A CLTCL1 MYO1C TRIM4 MYCBP2 CD109 KDM3B DHX9 CLTC OSBPL8 TAF1 GNB3 SYNCRIP PDCD6IP CAPZA1 COPG2 RICTOR SPECC1L IGF2R EGFR EIF2AK2 | 3.73e-05 | 727 | 232 | 22 | int:CHMP4B |
| Interaction | CTNNB1 interactions | ARHGAP32 ERBB2 MYO1C SRP9 KAT2A PTEN DHX9 SLIT2 KAT2B KDR EIF4E3 KIF5B VASP SYNCRIP ANKRD35 PDCD6IP CAPZA1 ARFGEF2 ARFGEF1 BRCC3 SPECC1L NR3C1 SEC24C EGFR TNKS IKBKB HTT | 4.12e-05 | 1009 | 232 | 27 | int:CTNNB1 |
| Interaction | EXOC1 interactions | 4.26e-05 | 143 | 232 | 9 | int:EXOC1 | |
| Interaction | DEPTOR interactions | 4.47e-05 | 82 | 232 | 7 | int:DEPTOR | |
| Interaction | GJA1 interactions | ARHGAP32 ERBB2 NSDHL PIK3C3 CLTC VPS13A OSBPL8 GOLGA4 DENND5B COPG1 ARFGEF1 COPG2 RICTOR ARCN1 IGF2R EGFR UNC5C ROBO1 HTT | 4.84e-05 | 583 | 232 | 19 | int:GJA1 |
| Interaction | KIF5B interactions | PSMA4 DHX9 NUAK1 COG6 KIF5B KIF5C RMC1 GOLGA4 CAPZA1 RICTOR IDH2 FHIP2A AZIN1 HTT | 5.49e-05 | 348 | 232 | 14 | int:KIF5B |
| Interaction | USP18 interactions | 6.50e-05 | 60 | 232 | 6 | int:USP18 | |
| Interaction | STX6 interactions | ERBB2 COG6 OSBPL8 GOLGA4 BMP2K STXBP5 VPS50 ARFGEF2 ARFGEF1 RICTOR IGF2R GTF3C2 UNC5C TRAPPC10 ROBO1 HTT | 6.73e-05 | 448 | 232 | 16 | int:STX6 |
| Interaction | KIF5C interactions | 7.04e-05 | 88 | 232 | 7 | int:KIF5C | |
| Interaction | HERC2 interactions | ABR MYCBP2 CLTC KIF5B TAF1 KIF5C HERC1 MED17 EIF3M COPG1 COPG2 SPECC1L USP16 GTF3C2 EGFR EPCAM NIN | 7.85e-05 | 503 | 232 | 17 | int:HERC2 |
| Interaction | RAB4A interactions | NSDHL PIK3C3 RABGAP1L VPS13A CPNE3 OSBPL8 GOLGA4 SYNE1 VPS50 VPS8 ARFGEF2 ARFGEF1 NR3C1 IGF2R EGFR HTT | 8.48e-05 | 457 | 232 | 16 | int:RAB4A |
| Interaction | ELOVL5 interactions | NSDHL VPS13A OSBPL8 GOLGA4 TAPT1 COPG1 TSNARE1 ARFGEF2 ARFGEF1 COPG2 NR3C1 ARCN1 GPR107 IGF2R | 8.87e-05 | 364 | 232 | 14 | int:ELOVL5 |
| Interaction | TSC1 interactions | ARHGAP32 KAT2A COG6 PIK3C3 KIF5C WNK3 GOLGA4 ANKRD35 RICTOR IGF2R SEC24C EGFR TNKS IKBKB | 9.39e-05 | 366 | 232 | 14 | int:TSC1 |
| Interaction | PDE7A interactions | 1.06e-04 | 22 | 232 | 4 | int:PDE7A | |
| Interaction | SMAD1 interactions | ERBB2 KDM3B KAT2A KAT2B CPNE3 TAF1 MED17 AKR1B1 TAPT1 GTF3C2 SS18L1 | 1.25e-04 | 243 | 232 | 11 | int:SMAD1 |
| Interaction | RHOV interactions | MYO1C SRP9 GIT2 ARHGEF7 CLTC GIT1 RICTOR CSE1L EGFR ROBO1 MAD2L1 | 1.25e-04 | 243 | 232 | 11 | int:RHOV |
| Interaction | DRD1 interactions | 1.28e-04 | 23 | 232 | 4 | int:DRD1 | |
| Interaction | CD244 interactions | 1.30e-04 | 43 | 232 | 5 | int:CD244 | |
| Interaction | TFPI2 interactions | 1.30e-04 | 43 | 232 | 5 | int:TFPI2 | |
| Interaction | CIT interactions | DDX47 ARHGAP32 CLTCL1 MYO1C TRIM4 SMC1A CD109 SRP9 PTEN DHX9 ODR4 CLTC ACSBG2 HERC1 EIF3M GOLGA4 SYNCRIP ANKRD35 TAPT1 DSCAM NUP107 STXBP5 SYNE1 CAPZA1 HEATR1 SPECC1L PWP1 CSE1L SEC24C GTF3C2 PDCD11 EIF2AK2 NIN | 1.33e-04 | 1450 | 232 | 33 | int:CIT |
| Interaction | CTDP1 interactions | MED17 COPG1 ARFGEF2 ARFGEF1 COPG2 RICTOR EGFR ATM MAD2L1 HTT | 1.49e-04 | 207 | 232 | 10 | int:CTDP1 |
| Interaction | FOXP3 interactions | ZNF346 GIT2 UFD1 TAF1 PDCD6IP NUP107 COPG2 HEATR1 NR3C1 ARCN1 CSE1L SEC24C GTF3C2 ATM MAD2L1 | 1.55e-04 | 432 | 232 | 15 | int:FOXP3 |
| Interaction | SH2B3 interactions | 1.79e-04 | 25 | 232 | 4 | int:SH2B3 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.58e-05 | 161 | 152 | 8 | 593 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 3.63e-04 | 17 | 152 | 3 | 1059 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.63e-04 | 17 | 152 | 3 | 486 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 4.17e-04 | 4 | 152 | 2 | 1096 | |
| GeneFamily | BRCA1 A complex|BRISC complex | 4.17e-04 | 4 | 152 | 2 | 1375 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 8.83e-04 | 51 | 152 | 4 | 870 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.43e-03 | 7 | 152 | 2 | 785 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.86e-03 | 394 | 152 | 10 | 471 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-03 | 160 | 152 | 6 | 555 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.43e-03 | 9 | 152 | 2 | 1234 | |
| GeneFamily | Copines | 2.43e-03 | 9 | 152 | 2 | 829 | |
| GeneFamily | CD molecules|Tetraspanins | 2.64e-03 | 33 | 152 | 3 | 768 | |
| GeneFamily | ATAC complex | 5.15e-03 | 13 | 152 | 2 | 1058 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 HIVEP1 MYCBP2 KDM3B EXT1 PTEN SLIT2 NUAK1 PIK3C3 ARHGEF7 RABGAP1L VPS13A OSBPL8 KIF5C GOLGA4 ADGRA3 UBR2 SUPT20H BMP2K ARFGEF1 SPECC1L NR3C1 AZIN1 IGF2R CSE1L GTF3C2 EGFR TNKS PLCE1 | 8.30e-10 | 856 | 234 | 29 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RIPOR2 KDM3B PTEN ADA NSDHL ABRAXAS2 NOD1 DENND10 ARHGEF7 RABGAP1L OSBPL8 EIF3M GOLGA4 UBR2 SUPT20H BMP2K CAPZA1 CENPU ARFGEF2 NR3C1 ATP10A GPR107 PWP1 CSE1L EIF2B1 GYG1 TRAPPC10 ATM IKBKB MAD2L1 | 4.82e-07 | 1215 | 234 | 30 | M41122 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | ABR DCAF8 EXT1 TBC1D16 PIK3C3 ODR4 RABGAP1L PGAP1 CPNE3 KDR ADGRA3 SYNCRIP CENPU ARFGEF2 ARFGEF1 IDH2 ATP10A GPR107 AZIN1 IGF2R TRAPPC10 ATM SORL1 | 7.51e-07 | 790 | 234 | 23 | M12490 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RIPOR2 ABR MYCBP2 PTEN CSMD3 TBC1D32 PRDM8 F11R NUAK1 SPOCK3 CNTN5 RABGAP1L PGAP1 ANKAR KIF5C KLHL14 HERC1 WNK3 DSCAM STXBP5 ARFGEF1 RICTOR CHST1 ZNF248 TSPAN7 ROBO1 TNKS | 2.34e-06 | 1106 | 234 | 27 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KIF18A ZNF486 MYCBP2 PSMA4 EXT1 COL25A1 PTEN COG6 RABGAP1L OSBPL8 KIF5B GOLGA4 GAREM1 CENPU ARFGEF1 BRCC3 ATM SORL1 NIN | 7.72e-06 | 656 | 234 | 19 | M18979 |
| Coexpression | GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN | RIPOR2 DCAF8 MYCBP2 PTEN RABGAP1L GPR34 ZDHHC14 CENPU ATM SORL1 | 1.30e-05 | 199 | 234 | 10 | M7782 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 MYCBP2 EXT1 NUAK1 PIK3C3 ARHGEF7 VPS13A OSBPL8 KIF5C GOLGA4 UBR2 ARFGEF1 SPECC1L NR3C1 EGFR | 2.15e-05 | 466 | 234 | 15 | M13522 |
| Coexpression | HALLMARK_PROTEIN_SECRETION | 2.51e-05 | 96 | 234 | 7 | M5910 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RIPOR2 HIVEP1 MYO1C COL25A1 RABGAP1L VPS13A MED12L OSBPL8 KIF5B MME ZDHHC14 ZNF300 RICTOR MINDY2 ATP10A LIFR ZBTB46 GYG1 UBR3 ULK2 PLCE1 | 2.97e-05 | 854 | 234 | 21 | M1533 |
| Coexpression | TCGA_GLIOBLASTOMA_MUTATED | 3.81e-05 | 8 | 234 | 3 | M19387 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | ERBB2 DCAF8 KDM3B PTEN RNF217 TIAM2 TBC1D32 KAT2B F11R EIF4E3 HERC1 MRI1 SUPT20H GUSBP1 LIFR ZBTB46 ERCC6L2 SPRED1 EPCAM SORL1 | 4.15e-05 | 807 | 234 | 20 | M16651 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RIPOR2 HIVEP1 MYO1C COL25A1 RABGAP1L VPS13A MED12L OSBPL8 KIF5B MME ZDHHC14 ZNF300 RICTOR MINDY2 ATP10A LIFR ZBTB46 GYG1 UBR3 ULK2 PLCE1 | 5.21e-05 | 888 | 234 | 21 | MM1018 |
| Coexpression | CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL | 5.24e-05 | 146 | 234 | 8 | M39301 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 7.69e-05 | 198 | 234 | 9 | M4415 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 8.30e-05 | 200 | 234 | 9 | M4894 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 8.30e-05 | 200 | 234 | 9 | M7831 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | HIVEP1 PER1 PBLD PLIN2 UFD1 A2ML1 CYP7B1 COPG1 CYP3A43 IDH2 FHIP2A MINDY2 LIFR SLC25A10 | 8.67e-05 | 467 | 234 | 14 | MM1233 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.09e-04 | 162 | 234 | 8 | M45037 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | KIF18A RABGAP1L VPS13A OSBPL8 KIF5B SYNCRIP ATE1 MINDY2 ERCC6L2 | 7.38e-06 | 123 | 228 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-1 | HIVEP1 F11R NUAK1 RABGAP1L CYP7B1 PLD4 ANKRD35 DSCAM BMP2K ZDHHC14 TSPAN33 LIFR GYG1 SPRED1 ZC3H12C | 1.47e-05 | 376 | 228 | 15 | GSM854290_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ZNF717 KIF18A RABGAP1L PGAP1 VPS13A MED12L PRMT9 TAF1 HERC1 WNK3 NUP107 VPS50 ARFGEF2 COPG2 HEATR1 STK31 ATP10A USP26 SNX25 ERCC6L2 ATM EPCAM HTT | 2.72e-05 | 820 | 228 | 23 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.14e-08 | 193 | 237 | 10 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 9.60e-08 | 194 | 237 | 10 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.01e-07 | 195 | 237 | 10 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.11e-07 | 197 | 237 | 10 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.28e-07 | 200 | 237 | 10 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.28e-07 | 200 | 237 | 10 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.01e-07 | 182 | 237 | 9 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.59e-07 | 184 | 237 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.19e-07 | 139 | 237 | 8 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.24e-07 | 189 | 237 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.61e-07 | 190 | 237 | 9 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.61e-07 | 190 | 237 | 9 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.00e-07 | 191 | 237 | 9 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.00e-07 | 191 | 237 | 9 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-06 | 194 | 237 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.07e-06 | 195 | 237 | 9 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 195 | 237 | 9 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-06 | 196 | 237 | 9 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.16e-06 | 197 | 237 | 9 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-06 | 199 | 237 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 199 | 237 | 9 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | KIF18A NSDHL VPS13A CPNE3 GOLGA4 STXBP5 ARFGEF2 HEATR1 CSE1L | 1.32e-06 | 200 | 237 | 9 | 118321ac443feb42aee171baccfc4610f00a8822 |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-06 | 200 | 237 | 9 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-06 | 150 | 237 | 8 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 162 | 237 | 8 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 162 | 237 | 8 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 162 | 237 | 8 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.71e-06 | 163 | 237 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-06 | 167 | 237 | 8 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.70e-06 | 170 | 237 | 8 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.38e-06 | 183 | 237 | 8 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.38e-06 | 183 | 237 | 8 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.18e-06 | 186 | 237 | 8 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 187 | 237 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 187 | 237 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.47e-06 | 187 | 237 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.47e-06 | 187 | 237 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-06 | 188 | 237 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-06 | 188 | 237 | 8 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 8.05e-06 | 135 | 237 | 7 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.07e-06 | 189 | 237 | 8 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-06 | 189 | 237 | 8 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-06 | 189 | 237 | 8 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.07e-06 | 189 | 237 | 8 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.39e-06 | 190 | 237 | 8 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.39e-06 | 190 | 237 | 8 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 8.39e-06 | 190 | 237 | 8 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.39e-06 | 190 | 237 | 8 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 191 | 237 | 8 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.72e-06 | 191 | 237 | 8 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-06 | 191 | 237 | 8 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.72e-06 | 191 | 237 | 8 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-06 | 191 | 237 | 8 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.72e-06 | 191 | 237 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.72e-06 | 191 | 237 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.72e-06 | 191 | 237 | 8 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.72e-06 | 191 | 237 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 9.06e-06 | 192 | 237 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.06e-06 | 192 | 237 | 8 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.06e-06 | 192 | 237 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.41e-06 | 193 | 237 | 8 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 9.41e-06 | 193 | 237 | 8 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.41e-06 | 193 | 237 | 8 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 9.41e-06 | 193 | 237 | 8 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.41e-06 | 193 | 237 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Endothelial-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.77e-06 | 194 | 237 | 8 | abea887dd472c1a0d572e690bc8914c1b94712ad | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.77e-06 | 194 | 237 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.77e-06 | 194 | 237 | 8 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 194 | 237 | 8 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.01e-05 | 195 | 237 | 8 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | distal-Hematologic-Classical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.01e-05 | 195 | 237 | 8 | 32c34741e35006b7238896fd04a497011297dd22 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 195 | 237 | 8 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 195 | 237 | 8 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.01e-05 | 195 | 237 | 8 | 6f417bb464b8ae6a50bbab5db5a6d5760c02122f | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.05e-05 | 196 | 237 | 8 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|World / Lineage and Cell class | 1.05e-05 | 196 | 237 | 8 | 4cb046883e56524963f6469ddb3b82c3c9853379 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.05e-05 | 196 | 237 | 8 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 196 | 237 | 8 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | distal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-05 | 196 | 237 | 8 | c1f3334bc09f5d0cfb9d998a3a64f0700426a357 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.07e-05 | 141 | 237 | 7 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.09e-05 | 197 | 237 | 8 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | distal-Hematologic-Classical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-05 | 197 | 237 | 8 | 9f4b0857012cd503e668bac115010216a946f73c | |
| ToppCell | distal-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-05 | 197 | 237 | 8 | 9a1c9221904ad1e46e64e3785516804e87128adc | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.13e-05 | 198 | 237 | 8 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.13e-05 | 198 | 237 | 8 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-05 | 198 | 237 | 8 | e76061e66f6d60f5735962aa7777dda8958caed9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 199 | 237 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-05 | 199 | 237 | 8 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 199 | 237 | 8 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 199 | 237 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-05 | 199 | 237 | 8 | 119807ea333d1dc7743c6b9f03a2c63e09e19541 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-05 | 199 | 237 | 8 | 691e04871cd6cac0ea5fca1b7fd6421df9315db6 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-05 | 199 | 237 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | B_cell_maturation-pre-B|World / Lineage and Cell class | 1.22e-05 | 200 | 237 | 8 | acb9ad7e3c05ec38e9700fb27b6eed8eaa565689 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 1.22e-05 | 200 | 237 | 8 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 200 | 237 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-05 | 149 | 237 | 7 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 150 | 237 | 7 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 159 | 237 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 162 | 237 | 7 | 768a566e76923323c1f197f60bab472a8784490b | |
| Drug | 4-aminopyrimidine-5-carbaldehyde | 1.09e-06 | 3 | 235 | 3 | CID011228787 | |
| Drug | EGFR/ErbB2 inhibitor | 4.31e-06 | 4 | 235 | 3 | CID009843206 | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | PER1 GIT2 F11R SUPT20H BMP2K ARFGEF2 ARFGEF1 CSE1L GTF3C2 ATM IKBKB | 6.18e-06 | 195 | 235 | 11 | 1657_DN |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.15e-06 | 198 | 235 | 11 | 3423_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | KIF18A ASXL1 GIT2 KAT2A EIF3M DSCAM BMP2K GPR107 CSE1L IKBKB ARHGAP45 | 7.50e-06 | 199 | 235 | 11 | 6977_DN |
| Disease | stomach cancer (is_marker_for) | 1.85e-06 | 142 | 230 | 9 | DOID:10534 (is_marker_for) | |
| Disease | Malignant neoplasm of prostate | ERBB2 ABR PTEN CPNE3 CYP7B1 MME GOLGA4 CYP3A43 NR3C1 TERT LIFR IGF2R EGFR ROBO1 ATM EPCAM EIF2AK2 | 7.76e-06 | 616 | 230 | 17 | C0376358 |
| Disease | Prostatic Neoplasms | ERBB2 ABR PTEN CPNE3 CYP7B1 MME GOLGA4 CYP3A43 NR3C1 TERT LIFR IGF2R EGFR ROBO1 ATM EPCAM EIF2AK2 | 7.76e-06 | 616 | 230 | 17 | C0033578 |
| Disease | brain disease (implicated_via_orthology) | 9.19e-06 | 6 | 230 | 3 | DOID:936 (implicated_via_orthology) | |
| Disease | Liver carcinoma | KIF18A TRAIP PTEN SLIT2 CENPU TERT LIFR MFSD2A IGF2R EGFR ROBO1 MTBP ATM CDC6 MAD2L1 | 1.20e-05 | 507 | 230 | 15 | C2239176 |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.27e-05 | 19 | 230 | 4 | DOID:2876 (is_marker_for) | |
| Disease | Carcinoma of lung | 2.83e-05 | 23 | 230 | 4 | C0684249 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.38e-05 | 24 | 230 | 4 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.38e-05 | 24 | 230 | 4 | C3805278 | |
| Disease | Adenocarcinoma | 3.62e-05 | 116 | 230 | 7 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 3.62e-05 | 116 | 230 | 7 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.62e-05 | 116 | 230 | 7 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.62e-05 | 116 | 230 | 7 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.62e-05 | 116 | 230 | 7 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.62e-05 | 116 | 230 | 7 | C0205641 | |
| Disease | Malignant neoplasm of breast | ERBB2 CATSPERE CD109 PER1 PTEN KDR MME EIF3M VWF SYNE1 ARFGEF2 XDH TERT MOSPD1 ZNF546 EPG5 EGFR ROBO1 CDA ATM IKBKB SORL1 | 3.89e-05 | 1074 | 230 | 22 | C0006142 |
| Disease | Cholangiocarcinoma | 4.70e-05 | 26 | 230 | 4 | C0206698 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.74e-05 | 169 | 230 | 8 | DOID:3908 (is_marker_for) | |
| Disease | von Willebrand's disease 2 (is_marker_for) | 6.05e-05 | 2 | 230 | 2 | DOID:0060574 (is_marker_for) | |
| Disease | Malignant Neoplasms | 6.78e-05 | 128 | 230 | 7 | C0006826 | |
| Disease | hippocampus volume change measurement, age at assessment | 7.33e-05 | 29 | 230 | 4 | EFO_0008007, EFO_0021492 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.14e-04 | 139 | 230 | 7 | DOID:3908 (is_implicated_in) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.34e-04 | 63 | 230 | 5 | DOID:0050866 (is_marker_for) | |
| Disease | Pancreatic Neoplasm | 1.36e-04 | 100 | 230 | 6 | C0030297 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.37e-04 | 301 | 230 | 10 | DOID:684 (is_marker_for) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.48e-04 | 145 | 230 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of pancreas | 1.52e-04 | 102 | 230 | 6 | C0346647 | |
| Disease | phoneme awareness | 1.60e-04 | 14 | 230 | 3 | EFO_0021812 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.68e-04 | 148 | 230 | 7 | C0279702 | |
| Disease | cerebral cavernous malformation (is_marker_for) | 1.81e-04 | 3 | 230 | 2 | DOID:0060669 (is_marker_for) | |
| Disease | Intestinal Obstruction | 1.81e-04 | 3 | 230 | 2 | C0021843 | |
| Disease | Neoplasm Recurrence, Local | 2.39e-04 | 39 | 230 | 4 | C0027643 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.42e-04 | 157 | 230 | 7 | DOID:224 (biomarker_via_orthology) | |
| Disease | colorectal cancer (is_marker_for) | 2.42e-04 | 157 | 230 | 7 | DOID:9256 (is_marker_for) | |
| Disease | factor VIII measurement, coronary artery disease | 2.65e-04 | 113 | 230 | 6 | EFO_0001645, EFO_0004630 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.87e-04 | 74 | 230 | 5 | DOID:3748 (is_marker_for) | |
| Disease | urinary bladder cancer (is_implicated_in) | 3.25e-04 | 76 | 230 | 5 | DOID:11054 (is_implicated_in) | |
| Disease | Chorioangioma | 3.59e-04 | 4 | 230 | 2 | C0677608 | |
| Disease | Angioma | 3.59e-04 | 4 | 230 | 2 | C1959588 | |
| Disease | monocyte chemotactic protein-2 measurement | 3.59e-04 | 4 | 230 | 2 | EFO_0010789 | |
| Disease | CYSTIC FIBROSIS MODIFIER 1 | 3.59e-04 | 4 | 230 | 2 | C1859047 | |
| Disease | Hemangioma, Intramuscular | 3.59e-04 | 4 | 230 | 2 | C0205789 | |
| Disease | Histiocytoid hemangioma | 3.59e-04 | 4 | 230 | 2 | C0205788 | |
| Disease | Hemangioma | 3.59e-04 | 4 | 230 | 2 | C0018916 | |
| Disease | Usher Syndrome | 3.59e-04 | 4 | 230 | 2 | C0271097 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 4.17e-04 | 45 | 230 | 4 | DOID:8947 (biomarker_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.17e-04 | 45 | 230 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Adenocarcinoma of prostate | 4.83e-04 | 20 | 230 | 3 | C0007112 | |
| Disease | forced expiratory volume | TRAIP PSMA4 PCDH15 KDR EIF4E3 RMC1 GAREM1 DSCAM BMP2K SYNE1 ARFGEF2 ATE1 STK31 CSE1L SEC24C ERCC6L2 | 5.04e-04 | 789 | 230 | 16 | EFO_0004314 |
| Disease | renal cell carcinoma (is_marker_for) | 5.17e-04 | 128 | 230 | 6 | DOID:4450 (is_marker_for) | |
| Disease | hypertension (implicated_via_orthology) | 5.17e-04 | 128 | 230 | 6 | DOID:10763 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | RIPOR2 NUP210L SRP9 KAT2A PTEN TBC1D16 KAT2B NOD1 CNTN5 VPS13A MARCHF8 SPECC1L TERT AZIN1 CDA ATM | 5.77e-04 | 799 | 230 | 16 | EFO_0010701 |
| Disease | response to bronchodilator, response to corticosteroid | 5.96e-04 | 5 | 230 | 2 | GO_0031960, GO_0097366 | |
| Disease | Cetuximab response | 5.96e-04 | 5 | 230 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 5.96e-04 | 5 | 230 | 2 | cv:CN077999 | |
| Disease | Glioma | 6.06e-04 | 87 | 230 | 5 | C0017638 | |
| Disease | Nasopharyngeal carcinoma | 6.45e-04 | 22 | 230 | 3 | C2931822 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 7.38e-04 | 23 | 230 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | Uterine leiomyoma | 7.43e-04 | 91 | 230 | 5 | HP_0000131 | |
| Disease | Small cell carcinoma of lung | 8.38e-04 | 54 | 230 | 4 | C0149925 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 8.38e-04 | 24 | 230 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | Biliary Tract Neoplasm | 8.89e-04 | 6 | 230 | 2 | C0005426 | |
| Disease | GLIOMA SUSCEPTIBILITY 1 | 8.89e-04 | 6 | 230 | 2 | C2750850 | |
| Disease | Mammary Carcinoma, Animal | 8.91e-04 | 142 | 230 | 6 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 8.91e-04 | 142 | 230 | 6 | C0024667 | |
| Disease | Adenocarcinoma of large intestine | 9.47e-04 | 96 | 230 | 5 | C1319315 | |
| Disease | uterine fibroid | 9.94e-04 | 199 | 230 | 7 | EFO_0000731 | |
| Disease | Autistic Disorder | 1.07e-03 | 261 | 230 | 8 | C0004352 | |
| Disease | urate measurement, spine bone mineral density | 1.10e-03 | 58 | 230 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.21e-03 | 206 | 230 | 7 | C0152013 | |
| Disease | Congenital Pain Insensitivity | 1.24e-03 | 7 | 230 | 2 | C0002768 | |
| Disease | peritonitis (biomarker_via_orthology) | 1.24e-03 | 7 | 230 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | 2'-deoxyuridine measurement | 1.24e-03 | 7 | 230 | 2 | EFO_0800643 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.24e-03 | 7 | 230 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Pituitary stalk interruption syndrome | 1.24e-03 | 7 | 230 | 2 | C4053775 | |
| Disease | Mammary Neoplasms, Experimental | 1.40e-03 | 155 | 230 | 6 | C0024668 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.45e-03 | 156 | 230 | 6 | C0007131 | |
| Disease | Myeloid Leukemia, Chronic | 1.47e-03 | 29 | 230 | 3 | C0023473 | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.49e-03 | 63 | 230 | 4 | DOID:2671 (is_marker_for) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.60e-03 | 108 | 230 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | cleft palate (implicated_via_orthology) | 1.64e-03 | 8 | 230 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | cortical surface area change measurement | 1.64e-03 | 8 | 230 | 2 | EFO_0021503 | |
| Disease | age at onset, glioblastoma multiforme | 1.64e-03 | 8 | 230 | 2 | EFO_0000519, EFO_0004847 | |
| Disease | breast carcinoma (is_marker_for) | 1.78e-03 | 66 | 230 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Severe Congenital Microcephaly | 1.79e-03 | 31 | 230 | 3 | C3853041 | |
| Disease | Carcinomatosis | 1.81e-03 | 163 | 230 | 6 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.81e-03 | 163 | 230 | 6 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.81e-03 | 163 | 230 | 6 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.81e-03 | 163 | 230 | 6 | C0205696 | |
| Disease | Carcinoma | 1.86e-03 | 164 | 230 | 6 | C0007097 | |
| Disease | Microcephaly | 1.88e-03 | 67 | 230 | 4 | C0025958 | |
| Disease | Squamous cell carcinoma of lung | 1.96e-03 | 32 | 230 | 3 | C0149782 | |
| Disease | hemangiopericytoma (is_marker_for) | 2.10e-03 | 9 | 230 | 2 | DOID:264 (is_marker_for) | |
| Disease | velocardiofacial syndrome (implicated_via_orthology) | 2.10e-03 | 9 | 230 | 2 | DOID:12583 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 2.10e-03 | 9 | 230 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Glioma | 2.10e-03 | 9 | 230 | 2 | cv:C0017638 | |
| Disease | glioblastoma multiforme | 2.10e-03 | 9 | 230 | 2 | EFO_0000519 | |
| Disease | uterine fibroid, Menorrhagia | 2.10e-03 | 9 | 230 | 2 | EFO_0000731, HP_0000132 | |
| Disease | intermittent Staphylococcus aureus carrier status | 2.10e-03 | 9 | 230 | 2 | EFO_0007758 | |
| Disease | 22q11 partial monosomy syndrome | 2.10e-03 | 9 | 230 | 2 | C3266101 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CGQVILKTELNNYLS | 451 | Q9BXU7 | |
| YKVALETAEKCSQSN | 191 | Q12979 | |
| IESQKANQCAVLIYT | 216 | Q5FVE4 | |
| IKNATYIKCNISDVQ | 536 | Q9UKF5 | |
| CAVSSKYQTVEKLQQ | 226 | Q9H0S4 | |
| VTSANIQEFAGCKKI | 356 | P04626 | |
| VGAQNTVICSKLAAK | 51 | P16422 | |
| CVQYVQKHISAENTK | 186 | Q9UNN8 | |
| NYNLTVVKNKLACVI | 881 | Q9HCE0 | |
| YIAVLTKGICQSEEN | 126 | Q6NSW5 | |
| LCKNIQIIATYAQTE | 141 | Q99424 | |
| YAGLQTASVEKAQCK | 1546 | Q9P281 | |
| VELCKKYQQQTVVAI | 166 | P00813 | |
| QVYNALQEKVQAVCA | 211 | Q15018 | |
| KRNTIYNAAIQKAVC | 161 | Q6P2P2 | |
| YNAAIQKAVCLGSKS | 166 | Q6P2P2 | |
| LNTSNREVKVYVCKS | 766 | Q6P2P2 | |
| TVCNVTKKIFLVIYN | 411 | Q5SY80 | |
| YSKACPIAQKVFQIA | 686 | Q5SY80 | |
| YVLQGAKSITCQRIA | 516 | Q7Z407 | |
| KYKSLVTTAIQQCVQ | 376 | Q96NH3 | |
| SSGCKVKETNVNYTI | 2701 | Q8IZF6 | |
| KYAAKVGVNILTCDN | 121 | O14977 | |
| IIVCGITAAANIKNY | 886 | Q8IWK6 | |
| IKQYLCVALSKNGVS | 481 | Q9Y6D6 | |
| CTVYAKTIDGQQTII | 141 | P52907 | |
| QQRKAITTKQSIYVC | 161 | Q9UPC5 | |
| LGAVQVSVCQKANTY | 251 | A8K2U0 | |
| AIKQYLCVALSKNGV | 431 | Q9Y6D5 | |
| SKVCKAAIATFYVNV | 271 | Q71F23 | |
| YKNSGVISVKQCEIT | 261 | O75131 | |
| CQKKTEGYQNIDITN | 1021 | Q69YQ0 | |
| QVIQCAYDIAKAAKQ | 736 | Q9Y2X7 | |
| VTQQVIQCAYDIAKA | 731 | Q14161 | |
| IQCAYDIAKAAKQLV | 736 | Q14161 | |
| AQILKVIEAYCTSAK | 711 | Q14155 | |
| LVQKTEECKTQAAAY | 316 | Q8N283 | |
| VGQLSCYDQAKQLVL | 176 | Q9UBX3 | |
| KNIVGYLDCAVNSIS | 106 | Q9NSY1 | |
| KIFYNNKQVSCTSVS | 506 | Q6DHV5 | |
| SVTFTKCLYAQLVQQ | 261 | O95905 | |
| NGSYCQQVDIEKLKI | 971 | Q8IXJ9 | |
| NQIKIKIYISQVCED | 171 | Q8N2F6 | |
| DKQETAVNIAYACKL | 891 | O60312 | |
| LTQEKLIQYCQSKGI | 191 | P15121 | |
| SYICLVKNTVTNARV | 266 | O94779 | |
| GTYLCLATEKVVQFQ | 326 | Q9UBG7 | |
| KTAIGNTLVQDICYS | 141 | P30039 | |
| IQTQSKVITYAGCIT | 86 | Q8NGA2 | |
| KNVLSAVCYCIVNKT | 341 | Q96P65 | |
| VNYCILKKQSVSVTL | 106 | Q5VW38 | |
| IVFCAVTSNEQVKGY | 576 | Q92830 | |
| EYENICGSQVNILSK | 176 | P57740 | |
| VYVGINEAKKNCIIV | 141 | Q9NWY4 | |
| TSQEQVYNDCAKKIV | 56 | P33176 | |
| AQCENKDVIAKYNGI | 811 | Q7Z5J8 | |
| VAKLSCGNVKVNAIY | 186 | Q8NGI2 | |
| YRTCVADAKTQKQEL | 466 | Q92619 | |
| GFINKIYAIQEVCVS | 876 | Q6DN14 | |
| SSACSKVKQTIYNNV | 951 | Q86YW9 | |
| LYKCSVQKLVVVISN | 76 | Q13257 | |
| RVIYTQLSKTVVCKQ | 606 | O14920 | |
| SFQVQCGLIVVAYKD | 286 | Q9BQP7 | |
| IVFCAVTSNEQVKGY | 571 | Q92831 | |
| SQGCVQKTYEEKISV | 1726 | Q13439 | |
| TQYVKICNEQKAEIL | 371 | Q8NI77 | |
| SLIKVAASCGAIQYI | 126 | Q7L2H7 | |
| VYCKIDQTQRKVVVS | 321 | Q7L2H7 | |
| NVTKKQYSLQQTCVF | 3456 | Q15751 | |
| CTKEAAQEAVKLYNN | 211 | O60506 | |
| AVCAKAQNKPFYVVA | 216 | Q14232 | |
| TLATLQYALACVKQV | 161 | O15534 | |
| KAVQADGQVKECYQS | 501 | Q8WUM4 | |
| IGQCSSQKDYVILAT | 31 | Q5SWX8 | |
| VVSCLYLGVKTNDLQ | 46 | Q9BXS0 | |
| LVNSESKANITCLVY | 381 | Q5TAQ9 | |
| YKFVNIQTKTVVVCC | 271 | Q9H706 | |
| TSKCKVQVNEVYGLV | 171 | P25021 | |
| VAVQKAKALYRSCIN | 131 | P08473 | |
| KVLCTTPNKYVVVDA | 51 | Q9UJG1 | |
| LRCIYETQSQKVGQL | 656 | Q9Y239 | |
| TSKYILANVGDQFCQ | 986 | Q7LBC6 | |
| ICQAILDSGKQYAIK | 201 | Q6ZV70 | |
| IYVQNCPETSKKNIF | 236 | Q5T0T0 | |
| CSIYNLKSREGNVKV | 121 | P16520 | |
| VIKQEKLGTVYCQAS | 291 | P04150 | |
| NQTKQIVEKYACTTR | 1301 | P00451 | |
| KVLITSQGYEQICKS | 476 | Q9NVC6 | |
| KETYNNIIRSGEKIC | 3246 | P98088 | |
| KETYNNIIRSGEKIC | 4651 | P98088 | |
| VAKVSCGNFKVNAIY | 186 | Q8NGI0 | |
| KNGCESKELVYLVQI | 146 | A7KAX9 | |
| SKELVYLVQIACQGK | 151 | A7KAX9 | |
| YVIQEQATVKLQSCI | 86 | P0C7M6 | |
| AKAKQLTVVGCQFTE | 596 | Q6R327 | |
| AAECASNLKKIYTVQ | 66 | Q8N5X7 | |
| AIIAEYKQICSQLST | 106 | B7ZAP0 | |
| AQISDAGIYKCVAIN | 1981 | Q96RW7 | |
| ADQLVINCKVYNVSS | 71 | A8MWK0 | |
| VNITCQKTGYSAILE | 591 | Q9BZF1 | |
| SLTQVKELGAVIYNC | 236 | Q96BZ4 | |
| TQKAYLLAAGVIVCI | 251 | Q8NA29 | |
| VQVQCINKKVGTIIY | 116 | Q96QU1 | |
| KLACSDTFINNVVIY | 186 | O76099 | |
| QIVKQSTELVCRAYG | 611 | Q9Y2V7 | |
| TIAKQANCPLYVTKV | 241 | O14531 | |
| VIISGNKNLCYANTI | 461 | P00533 | |
| AICEQAAETNNVYKK | 1421 | Q13315 | |
| LNYLEVAKVAQSCAA | 1936 | Q13315 | |
| GFAICQLNVVYNVKA | 1251 | Q6YHK3 | |
| ISALQKGYSKVLCQT | 306 | B1AJZ9 | |
| KALKQYTTTTCVQLQ | 1431 | P42858 | |
| YTTTTCVQLQKQVLD | 1436 | P42858 | |
| ALATQKYSVAVKCAT | 101 | P48735 | |
| LQQFGLVKDTCSYVN | 261 | P46976 | |
| ISVQNYKQVCKIAAL | 181 | Q9P2G3 | |
| KTVLVKECYSVFTNQ | 91 | Q9HB55 | |
| LVAAAKSQYCAQIIV | 501 | Q16394 | |
| KKRLTVNYEQCASGV | 111 | P19525 | |
| YNETKQVTVKLPNCA | 86 | Q86YW7 | |
| NYKNSGTVILNLCKI | 276 | Q96A23 | |
| YQKCSTLKEAAQSIE | 611 | Q6ZUT9 | |
| KQEGTCYQQAKLVLN | 151 | Q99741 | |
| KVVVVQAISALCQKY | 376 | Q9UBF2 | |
| AAVLQYASLVGQKCS | 496 | O95260 | |
| FQGVVYSANQCKALI | 256 | Q8N6U8 | |
| YSANQCKALITILVV | 261 | Q8N6U8 | |
| IYGKVIVCDNNKFIS | 196 | O75881 | |
| LNCSVKTVLQTQALY | 881 | Q9H583 | |
| KVVVVQAISALCQKY | 376 | Q9Y678 | |
| AYEKCISDNISNSVK | 4016 | Q8NDH2 | |
| CSLTDFQKAVYQTVL | 401 | Q5T890 | |
| YCDQLIKEAQKTAAV | 366 | Q5W0V3 | |
| YQISVKCSNQFKLEV | 21 | Q15486 | |
| YIAVLTKGICQSEEN | 126 | Q8TCE6 | |
| YSQCVIQKTGEELVK | 681 | Q7Z3Z3 | |
| QTGAYQTLAKECVAQ | 676 | P53992 | |
| VTALCDIKQAYTQFG | 111 | P25789 | |
| KNYCNIQVTKVTQVD | 476 | P48444 | |
| KGQTNILVYISICSL | 231 | Q6NVV3 | |
| CQAVIESSYQVAKAL | 526 | Q92523 | |
| TINDVVYVIDSCKQK | 721 | Q08211 | |
| INEANGKILSYNVSC | 561 | P42702 | |
| NCQKIAEYLSANVVS | 211 | Q96DY7 | |
| LYENGTLCSQKAVLI | 81 | Q5VU65 | |
| VVCQLKVKIYSSNSG | 216 | P60484 | |
| QGDTTRLVCYNNKIT | 66 | Q9Y624 | |
| VAKISCGNVRVNAIY | 186 | Q8NH53 | |
| YENVLICKQKTTETG | 136 | Q9GZY6 | |
| KFTQYGLVVQACNRA | 1056 | O60469 | |
| VDTKNNVLYKINICG | 56 | P11717 | |
| NVLYKINICGSVDIV | 61 | P11717 | |
| AVGNCSYNQLVEKII | 381 | Q8NBR6 | |
| SYNQLVEKIISCKQS | 386 | Q8NBR6 | |
| ETIKQVDLCNYVSVN | 161 | Q16518 | |
| TTYQVKVQVQCLSKA | 1621 | Q92673 | |
| TKYNLRITSGVVVCQ | 141 | Q86UA6 | |
| CKSAQASLKTYQNEV | 4496 | Q8NF91 | |
| CKQQTSLQAGVLDYE | 7341 | Q8NF91 | |
| NRAQDIQGIKIITYC | 521 | Q7LBE3 | |
| QVYNACAKQIVKDVL | 61 | O60282 | |
| KLVSICEQYGLQNVD | 206 | Q8N4C6 | |
| VTQVACFLAKQQNKY | 586 | Q5TAG4 | |
| AQDVIQQTLCKAKYS | 2161 | Q9P212 | |
| VEKSLYKEIQQCLVG | 351 | Q9H3E2 | |
| KTAQEIVNVCYQTLT | 1591 | P21675 | |
| KAVQQCLTDIFTSVY | 16 | Q9NQV8 | |
| YSCDLDINVQLKIGS | 11 | Q8NEB9 | |
| GICCQKYVKANISEQ | 316 | P48764 | |
| QLTEKCKNLQYGIES | 76 | P61647 | |
| TANKVGTYQLAIVAK | 256 | Q9BV20 | |
| VYTCKAINVLGEASV | 451 | Q13203 | |
| NITINCVKGINARYV | 3781 | O75592 | |
| NYIGTKNVIETCKEA | 121 | Q15738 | |
| VTQVYKQALEICSKL | 646 | O60285 | |
| GNKIITYNACVIQLF | 86 | A6NDL8 | |
| IYQAFKINVVSKCSA | 501 | Q75T13 | |
| VSQALALVGEKACYQ | 461 | Q8N3P4 | |
| CLKVYLSAQVQLGQV | 286 | Q8TC41 | |
| VYQAKCSLIKTHQEQ | 211 | Q9BVR0 | |
| ENQYAVICSEKQAKV | 911 | Q5T5C0 | |
| KQAKVISLPTQNCAY | 921 | Q5T5C0 | |
| TKNKVISFLGCVAQV | 126 | Q8NGG2 | |
| YCTQLVQQIVFSSKT | 751 | Q9Y4F9 | |
| GRVLYTCFQSIQAQK | 166 | P46736 | |
| YVLSQSEICKGKNIF | 71 | A8MXE2 | |
| KVNSVTEQCVAKIQY | 416 | Q8TBZ0 | |
| QQLLVCSQEAKKSAY | 16 | P32320 | |
| CFAETGQVQKIVLYA | 491 | Q00610 | |
| YIQAACKTGQIKEVE | 731 | Q00610 | |
| YIQAACKTGQIKEVE | 731 | P53675 | |
| CQQVLAQLGYKIAAS | 376 | O43916 | |
| LIQCILEYQSKGKTA | 31 | O75177 | |
| KTCEYVSEGNILIAQ | 426 | Q9BXU1 | |
| QIKGCLVTASADKYV | 396 | Q13610 | |
| KQTAAVALCQLAAYS | 631 | Q32MQ0 | |
| EKIKQYQAGQTVTCF | 1141 | Q14690 | |
| NRTIVEGYANVKKCS | 856 | Q96JG6 | |
| SKVIYTNGCIDKLVN | 216 | Q86UF1 | |
| NVIKVCASVTFKNYI | 56 | P55060 | |
| ALVITTQCEICYKGN | 1576 | Q96RL7 | |
| LSDAIQCYGVVQKKI | 346 | Q96NA8 | |
| CLAKNNSIYVVANIG | 126 | O95497 | |
| KTKEIGQCAIQISDY | 1646 | Q9BX84 | |
| CSSNQLGQVVDYVRK | 126 | Q9Y5T5 | |
| SVVLKQTYQEKVCGL | 981 | P04275 | |
| LNVYDVQLTKTGSVC | 886 | Q8IVF5 | |
| EYTQECKTKNANILG | 101 | Q96DM3 | |
| YVQRQISKECGSLKS | 211 | Q7Z699 | |
| KNCEVEQVKGVTYSL | 201 | Q9UG56 | |
| AALLIKYNTCVNATD | 886 | O95271 | |
| CEAGTQYQKTKLTIL | 341 | Q8NEM7 | |
| SVLDGEIIYSKNNVC | 31 | Q8TBP0 | |
| KNVCKIYLSQLQTGE | 146 | Q86UE3 | |
| NIGKVANYIKEQSTC | 1166 | Q14683 | |
| LNGQAVYAACQTILK | 1086 | P47989 | |
| QGYAACQTTKKVSRL | 1466 | O94813 | |
| YICQTLNVAGSIITK | 426 | Q9Y6N7 | |
| TSVDKSQYIGCKIAV | 226 | P49190 | |
| YQACVLGKQISVKCE | 166 | Q9BQ16 | |
| IINGQTVKLKYCFTC | 156 | Q8IZN3 | |
| LEGIYNCQKTSIVRV | 666 | Q9P2E3 | |
| VEVYSVQNILEKTCK | 1786 | Q9P2E3 | |
| EYEKACNNSAVIVQV | 241 | Q9BY31 | |
| DVCGKVFYQNSQLVR | 316 | Q6ZN19 | |
| INSVTAEKLIYNCAV | 956 | Q8IYT8 | |
| CLTTGDVIAINYNEK | 151 | Q92890 | |
| CKTCKIVLNSIEQYQ | 241 | Q9UL40 | |
| VVVNCGEALLKNNTY | 496 | Q6ZT12 | |
| TVAGRENNTCYAKII | 556 | Q86VQ6 | |
| KLEPQIAVANTYACK | 71 | Q99541 | |
| KCINGTDSVINYTII | 1206 | Q9UI33 | |
| LVCLVYKTDQAQDVK | 46 | P49458 | |
| NSIVLLGKSCQYVKE | 446 | Q6NXT6 | |
| AIYKVQCVATLQVGS | 531 | Q8WUA4 | |
| VNTQCGYDVRIQLKS | 196 | Q8NG11 | |
| TLVIQAANVSALYKC | 516 | P35968 | |
| AANVSALYKCEAVNK | 521 | P35968 | |
| VLCIQEYRKNSKVES | 11 | Q9C0D7 | |
| LLSSGTRKYVQVCVQ | 951 | P48553 | |
| NYSLEAVKVKTVCQI | 281 | Q9C037 | |
| QVIYTLQKAVNCTQK | 241 | Q8IWV8 | |
| VAATKVNQKGCYDLV | 191 | P41732 | |
| LTTTQSKIFQCGKYV | 146 | Q96H40 | |
| LSDTANYTCVAKNIV | 231 | O95185 | |
| IKYQDSVVNIQRTGC | 116 | Q02386 | |
| SKQNTGKSLYCQAIT | 1991 | P15822 | |
| VNSLQTVCTNIYKIL | 991 | O14746 | |
| LIQYQNVETKEKSCV | 256 | Q96RE9 | |
| TNKRSQIGETVCKYN | 231 | Q8NDW4 | |
| FKTLYCQVQKTSEQA | 56 | Q86UZ6 | |
| QSAVEQLAVYCVSLK | 191 | Q9BWF2 | |
| VINCAIVRGVKYNQA | 61 | P50552 | |
| CQNAAQIYRKVTSGI | 351 | Q9BYP7 | |
| YLVKGQCAKVSSIND | 266 | O00159 |